DERMÁLNÍ NÁHRADA MATRIDERM® – PRVNÍ ZKUŠENOSTI NA KLINICE POPÁLENINOVÉ MEDICÍNY 3. LF UK A FNKV

1. Jeschke MG., Pinto R., Kraft R., et al. Morbidity and survival probability in burn patients in modern burn care. Crit Care Med. 2015, 43:808–15.

2. Kraft R., Herndon DN., Al-Mousawi AM. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet. 2012, 379:1013–21.

3. Zajíček R., Grossová I., Šuca H. Experience with Integra at the Prague Burn Centre 2002–2016. Acta Chir Plast. 2017, 59:18–26.

4. Zajíček R., Sticová E., Šuca H., Brož L. Kožní náhrada Integra^® v klinické praxi. Rozhl Chir. 2013, 92:283–7.

5. Min JH., Yun IS., Lew DH., Roh TS., Lee WJ. The use of matriderm and autologous skin graft in the treatment of full thickness skin defects. Arch Plast Surg. 2014, 41:330–6.

6. Choi JY., Kim SH., Oh GJ., Roh SG., Lee NH., Yang KM. Management of defects on lower extremities with the use of Matriderm and skin graft. Arch Plast Surg. 2014, 41:337–43.

7. Heitland A., Piatkowski A., Noah EM., Pallua N. Update on the use of collagen/glycosaminoglycate skin substitute-six years of experiences with artificial skin in 15 German burn centers. Burns. 2004, 30:471–5.

8. Haslik W., Kamolz LP., Nathschläger G., Andel H., Meissl G., Frey M. First experiences with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns. 2007, 33:364–8.

9. Rehim SA., Singhal M., Chung KC. Dermal skin substitutes for upper limb reconstruction: current status, indications, and contraindications. Hand Clin. 2014, 30:239–52.

10. Bertolli E., Campagnari M., Molina AS., Macedo MP., Pinto CA., Cunha IW., et al. Artificial dermis (Matriderm®) followed by skin graft as an option in dermatofibrosarcoma protuberans with complete circumferential and peripheral deep margin assessment. Int Wound J. 2015, 12:545–7.

11. Heimbach D., Luterman A., Burke J., et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988, 208:313–20.

12. Anzarut A., Chen M., Shankowsky H., Tredget EE. Quality-of-life and outcome predictors following massive burn injury. Plast Reconstr Surg. 2005, 116:791–7.

13. Jones I., Currie L., Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002, 55:185–93.

14. Zajíček R. et al. Complex approach to skin repair in an extensively burned child: a case study. Journal of Wound Care, 2020, 29(8):458–63.

15. Jeon H., Kim J., Yeo H., Jeong H., Son D., Han K. Treatment of diabetic foot ulcer using matriderm in comparison with a skin graft. Arch Plast Surg. 2013, 40:403–8.

16. Min JH., Yun IS., Lew DH., Roh TS., Lee WJ. The use of matriderm and autologous skin graft in the treatment of full thickness skin defects. Arch Plast Surg. 2014, 41:330–6.

17.Hamuy R., Kinoshita N., Yoshimoto H., Hayashida K., Houbara S., Nakashima M, et al. One-stage, simultaneous skin grafting with artificial dermis and basic fibroblast growth factor successfully improves elasticity with maturation of scar formation. Wound Repair Regen. 2013, 21:141–54.

18. Böttcher-Haberzeth S., Biedermann T., Schiestl C., et al. Matriderm^® 1 mm versus Integra^® Single Layer 1.3 mm for one-step closure of full thickness skin defects: a comparative experimental study in rats. Pediatr Surg Int. 2012, 28:171–7.

19. Ramos G., Cornistein W., Cerino GT., Nacif G. Systemic antimicrobial prophylaxis in burn patients: systematic review. J Hosp Infect. 2017, 97:105–14.

20. van Zuijlen PP., van Trier AJ., Vloemans JF., Groenevelt F., Kreis RW., Middelkoop E. Graft survival and effectiveness of dermal substitution in burns and reconstructive surgery in a one-stage grafting model. Plast Reconstr Surg. 2000, 106:615–23.